JO3550B1 - مركب لمعالجة سرطان البروستاتا - Google Patents

مركب لمعالجة سرطان البروستاتا

Info

Publication number
JO3550B1
JO3550B1 JOP/2010/0128A JOP20100128A JO3550B1 JO 3550 B1 JO3550 B1 JO 3550B1 JO P20100128 A JOP20100128 A JO P20100128A JO 3550 B1 JO3550 B1 JO 3550B1
Authority
JO
Jordan
Prior art keywords
treatment
composition
prostate cancer
prostate
cancer
Prior art date
Application number
JOP/2010/0128A
Other languages
English (en)
Inventor
Cantor Per
Erichsen Lars
Kold Olesen Tine
Original Assignee
Ferring Int Center Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Int Center Sa filed Critical Ferring Int Center Sa
Application granted granted Critical
Publication of JO3550B1 publication Critical patent/JO3550B1/ar

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

يتعلق الاختراع الحالي بتوفير تركيبة لعلاج سرطان البروستاتا
JOP/2010/0128A 2009-05-01 2010-04-25 مركب لمعالجة سرطان البروستاتا JO3550B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09251242 2009-05-01
US18781909P 2009-06-17 2009-06-17

Publications (1)

Publication Number Publication Date
JO3550B1 true JO3550B1 (ar) 2020-07-05

Family

ID=65524059

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2010/0128A JO3550B1 (ar) 2009-05-01 2010-04-25 مركب لمعالجة سرطان البروستاتا

Country Status (2)

Country Link
JP (1) JP7085958B2 (ar)
JO (1) JO3550B1 (ar)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition

Also Published As

Publication number Publication date
JP7085958B2 (ja) 2022-06-17
JP2019031534A (ja) 2019-02-28

Similar Documents

Publication Publication Date Title
MX2011011431A (es) Composicion para el tratamiento de cancer de prostata.
MY160390A (en) Vinyl indazolyl compounds
EP2482849A4 (en) COMBINED IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
EP2461814A4 (en) PROSTATE CANCER TREATMENT
IL215108A0 (en) Amatoxin-armed target-binding moieties for the treatment of cancer
IL218575A0 (en) Treatment of cancer
IL224370B (en) Combined treatment of prostate cancer
PL2303021T3 (pl) Związki do leczenia nowotworu
MX2011006290A (es) Compuestos de aza-azuleno.
MX2013003594A (es) Inhibidores dobles de met y factor de crecimiento endotelial vascular (vegf) para el tratamiento de cancer de prostata resistente a la castracion y metastasis de osteoblasticas en los huesosl.
MX2009008132A (es) Terapia de combinacion con inhibidores de angiogenesis.
MX2014005458A (es) Inhibidor doble de met y del factor de crecimiento endotelial vascular (vegf) para el tratamiento del cáncer.
IL214746A0 (en) Substituted pyrimidines for the treatment of cancer
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
EP2331520A4 (en) ROSAMINE DERIVATIVES AS AGENTS FOR CANCER TREATMENT
ZA201300762B (en) Novel combination therapy for the treatment of cancer
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
HK1254607A1 (zh) 用於治療癌症的有機砷化合物
GB0916686D0 (en) Treatment of cancer
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
JO3550B1 (ar) مركب لمعالجة سرطان البروستاتا
WO2012037553A9 (en) Use of pkc-iota inhibitors for the treatment of breast cancer
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met
AU2009900764A0 (en) Treatment of cancer
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer